The serum levels of resistin in ankylosing spondylitis patients: A pilot study

Rheumatology International

Volumn 32, Issue 3, 2012, Pages 699-702

  Kocabas, Hilal ^a   Kocabas, Volkan ^b   Buyukbas, Sadik ^c   Melikoglu, Meltem Alkan ^d   Sezer, Ilhan ^e   Butun, Bulent ^f  

^a Division of Rheumatology   (Turkey)

^b Konya Beyhekim Government Hospital   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

^d Division of Rheumatology   (Turkey)

^e Antalya Teaching and Research Hospital   (Turkey)

^f AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Resistin

Indexed keywords

C REACTIVE PROTEIN; RESISTIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; BLOOD; HEALTH STATUS; HOSPITALIZATION; PATHOPHYSIOLOGY;

ADULT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HEALTH STATUS; HUMANS; MALE; PILOT PROJECTS; RESISTIN; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 84863299645     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1651-7     Document Type: Article

References (19)

1. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA (2001) The hormone resistin links obesity to diabetes. Proc Natl Acad Sci 98:502-506
2. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312 (Pubitemid 32151228)
3. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, Hébert CC (2000) FIZZ1 a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO (Eur Mol Biol Organ) J 19:4046-4055 (Pubitemid 30608543)
4. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA (2003) Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300:472-476 (Pubitemid 38375833)
5. Nagaev I, Smith U (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys ResCommun 285:561-564 (Pubitemid 32918109)
6. Lu SCç, Shieh WY, Chen CY, Hsu SC, Chen HL (2002) Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 530:158-162
7. Senolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzík M (2007) Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66(4):458-463 (Pubitemid 46580464)
8. Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R (2007) Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNFalpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 26:211-215 (Pubitemid 46020247)
9. Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D, ASASWorking Group (2006) First update of the international ASAS consensus statement for the use of anti- TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65:316-320 (Pubitemid 43268219)
10. Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D, ASASWorking Group (2003) International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62:817-824 (Pubitemid 37026490)
11. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sörensen H, Zeidler H, Thriene W, Sieper J (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359:1187-1193 (Pubitemid 34304258)
12. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR (2003) Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309:286-290 (Pubitemid 37025889)
13. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111:932-939 (Pubitemid 40279897)
14. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor- gamma action in humans. Diabetes 50:2199-2202 (Pubitemid 33641901)
15. Fain JN, Cheema PS, Bahouth SW, Lioyd Hiler M (2003) Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300:674-678 (Pubitemid 36268889)
16. Steppan CM, Lazar MA (2002) Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13:18-23 (Pubitemid 36734011)
17. Migita K, Maeda Y, Miyashita T, Kimura H, Nakamura M, Ishibashi H, Eguchi K (2006) The serum levels of resistin in rheumatoid arthritis patients. Clin Exper Rheum 24:698-701 (Pubitemid 46138804)
18. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174:5789-5795 (Pubitemid 40593223)
19. Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gómez-Reino JJ, Gualillo O (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65:1198-1201 (Pubitemid 44277396)